Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|
May 1, 1993
DNA analysis and persistent hypercalcitoninemia in medullary thyroid carcinoma
T K Jeng, C H Lee, H C Wang, et al.
Oncotarget
|
February 25, 2016
IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas
Peter S Kim, Anna R Kwilas, Wenxin Xu, et al.
Journal of Virology
|
April 3, 2015
In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice
Kieran Seay, Candice Church, Jian Hua Zheng, et al.
Oncotarget
|
June 3, 2017
New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity
Cavan P Bailey, Tulin Budak-Alpdogan, Christopher T Sauter, et al.
International Journal of Cancer
|
July 16, 2015
Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model
Dimitrios Mathios, Chul-Kee Park, Warren D Marcus, et al.
Cytokine
|
February 18, 2018
Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models
Bai Liu, Monica Jones, Lin Kong, et al.
Nature Biotechnology
|
July 10, 2018
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Li Tang, Yiran Zheng, Mariane Bandeira Melo, et al.
Cancer Research
|
May 7, 2013
Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myeloma
Wenxin Xu, Monica Jones, Bai Liu, et al.
The Journal of Biological Chemistry
|
September 22, 2016
A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses
Bai Liu, Lin Kong, Kaiping Han, et al.
Cancer Research
|
April 12, 2018
Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8<sup>+</sup> T Cells
C Bryce Johnson, Bennett R May, Brian P Riesenberg, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|
May 1, 1993
DNA analysis and persistent hypercalcitoninemia in medullary thyroid carcinoma
T K Jeng, C H Lee, H C Wang, et al.
Oncotarget
|
February 25, 2016
IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas
Peter S Kim, Anna R Kwilas, Wenxin Xu, et al.
Journal of Virology
|
April 3, 2015
In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice
Kieran Seay, Candice Church, Jian Hua Zheng, et al.
Oncotarget
|
June 3, 2017
New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity
Cavan P Bailey, Tulin Budak-Alpdogan, Christopher T Sauter, et al.
International Journal of Cancer
|
July 16, 2015
Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model
Dimitrios Mathios, Chul-Kee Park, Warren D Marcus, et al.
Cytokine
|
February 18, 2018
Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models
Bai Liu, Monica Jones, Lin Kong, et al.
Nature Biotechnology
|
July 10, 2018
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Li Tang, Yiran Zheng, Mariane Bandeira Melo, et al.
Cancer Research
|
May 7, 2013
Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor αSu/Fc fusion complex in syngeneic murine models of multiple myeloma
Wenxin Xu, Monica Jones, Bai Liu, et al.
The Journal of Biological Chemistry
|
September 22, 2016
A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses
Bai Liu, Lin Kong, Kaiping Han, et al.
Cancer Research
|
April 12, 2018
Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8<sup>+</sup> T Cells
C Bryce Johnson, Bennett R May, Brian P Riesenberg, et al.
Page
of 4